Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcelo P Fleck

Showing results (71-80 of 72) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 72 results.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 13, 2025
The effect of the number of psychiatric hospitalizations and diagnosis in serum levels of CCL11 and GDF15 in individuals with stable schizophrenia, bipolar disorder, and major depressive disorder: The compass between neuro and somatoprogressionMonise Costanzi, Jeferson F Goularte, Luis Henrique Toledo da Silva, et al.
BMJ Open|November 16, 2021
Which outcomes are most important to measure in patients with COVID-19 and how and when should these be measured? Development of an international standard set of outcomes measures for clinical use in patients with COVID-19: a report of the International Consortium for Health Outcomes Measurement (ICHOM) COVID-19 Working GroupWilliam H Seligman, Luz Fialho, Nick Sillett, et al.
Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 72 results.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 13, 2025
The effect of the number of psychiatric hospitalizations and diagnosis in serum levels of CCL11 and GDF15 in individuals with stable schizophrenia, bipolar disorder, and major depressive disorder: The compass between neuro and somatoprogressionMonise Costanzi, Jeferson F Goularte, Luis Henrique Toledo da Silva, et al.
BMJ Open|November 16, 2021
Which outcomes are most important to measure in patients with COVID-19 and how and when should these be measured? Development of an international standard set of outcomes measures for clinical use in patients with COVID-19: a report of the International Consortium for Health Outcomes Measurement (ICHOM) COVID-19 Working GroupWilliam H Seligman, Luz Fialho, Nick Sillett, et al.
Pageof 8